Novel propargylamine-based inhibitors of cholinesterases and monoamine oxidases: Synthesis, biological evaluation and docking study
作者:Martin Krátký、Quynh Anh Vu、Šárka Štěpánková、Annalisa Maruca、Tiago Barros Silva、Martin Ambrož、Václav Pflégr、Roberta Rocca、Katarína Svrčková、Stefano Alcaro、Fernanda Borges、Jarmila Vinšová
DOI:10.1016/j.bioorg.2021.105301
日期:2021.11
d ligands (MTDL) design. New propargylamine substituted derivatives combined with salicylic and cinnamic scaffolds were designed and synthesized as potential cholinesterases and monoamine oxidases (MAOs) inhibitors. They were evaluated in vitro for inhibition of acetyl- (AChE) and butyrylcholinesterase (BuChE) using Ellman’s method. All the compounds act as dual inhibitors. Most of the derivatives
一个分子中几种药效团的组合已成功用于多靶标配体 (MTDL) 设计。新的炔丙胺取代衍生物与水杨酸和肉桂酸支架结合被设计和合成为潜在的胆碱酯酶和单胺氧化酶 (MAO) 抑制剂。使用 Ellman 方法在 体外评估了它们对乙酰基 (AChE) 和丁酰胆碱酯酶 (BuChE) 的抑制作用。所有化合物均作为双重抑制剂。大多数衍生物是更强的 AChE 抑制剂,最佳活性显示 5-溴-N -(prop-2-yn-1-yl) 水杨酰胺1e (IC 50 = 8.05 µM)。氨基甲酸酯(4-溴-2-[(丙-2-炔-1-基)氨基甲酰基]苯基乙基(甲基)氨基甲酸酯2d和 2,4-dibromo-6-[(prop-2-yn-1-yl)carbamoyl] 苯基乙基(甲基)氨基甲酸酯2e对 BuChE 具有选择性且最活跃(25.10 和 26.09 µM)。4-Bromo-2-[(prop-2-yn-1-ylimino)methyl]phenol